💰The Funding Letter #1274: October 24

Island, MangoBoost, Blockaid, and more...

October 24, 2023


Good Morning! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. 🔥New Sales Gigs from HqO below!

Hit the Gong 🎉

Source: @sales_bant_er

Daily Deals 💸

🌎 Americas

Harpoon Therapeutics is a clinical-stage immunotherapy company that develops a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $150M, Post-IPO Equity

Round Investors: K2 HealthVentures, Invus, Soleus Capital, Ally Bridge Group

🚀Growth Focus: Develop programs from its platforms, including ongoing as well as future late-stage clinical studies of HPN328.

HQ: San Francisco, CA

Industry: Pharmaceutical Manufacturing

Employee Count: 53

Subscribe to TFL All-Access Tier to read the rest.

Become a paying subscriber of TFL All-Access Tier to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

  • • Exclusive Access to The Funding Letter, delivering hundreds of leads to your inbox each month
  • • Searchable weekly, monthly, and annual datasets of funding announcement leads, so you can quickly find the most relevant data
  • • The hottest Sales Gigs in the industry, sourced from the fastest growing startups
  • • ..and much more to come!